1. Home
  2. STEM vs GRML Comparison

STEM vs GRML Comparison

Compare STEM & GRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stem Inc.

STEM

Stem Inc.

N/A

Current Price

$2.38

Market Cap

34.6M

Sector

Technology

ML Signal

N/A

Logo Greenland Mines Ltd. Common Stock

GRML

Greenland Mines Ltd. Common Stock

N/A

Current Price

$3.82

Market Cap

29.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STEM
GRML
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
34.6M
29.2M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
STEM
GRML
Price
$2.38
$3.82
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $6.25
N/A
AVG Volume (30 Days)
165.5K
★ 2.8M
Earning Date
11-05-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.25
EPS
N/A
★ N/A
Revenue
★ $156,266,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.96
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 8.08
N/A
52 Week Low
$2.15
$0.16
52 Week High
$22.12
$18.21

Technical Indicators

Market Signals
Indicator
STEM
GRML
Relative Strength Index (RSI) 25.49 37.70
Support Level N/A $0.28
Resistance Level $6.02 $7.53
Average True Range (ATR) 0.30 0.64
MACD -0.08 -0.29
Stochastic Oscillator 13.14 1.36

Price Performance

Historical Comparison
STEM
GRML

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

About GRML Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: